EichorEICHOR
Location: Tamarac Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Tamarac

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · D&H Tamarac Research Center · Philip Morris Products S.A. · NCT07108166Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · D & H Tamarac Research Center · Walden Biosciences · NCT06466135Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · West Broward Rheumatology Associates · Pfizer · NCT05895786LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · D&H Tamarac Research Center · Pfizer · NCT07029828Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic D
Phase 2 · Site Number - 1004 · Immunovant Sciences GmbH · NCT06979531A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · BRCR Medical Center Inc /ID# 262344 · AbbVie · NCT04928846Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
NA · Barry University Clinical Research · Reprise Biomedical, Inc. · NCT06939686BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Florida Clinical Trials Group Tamarac · BeOne Medicines · NCT07492641A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0477 · Bristol-Myers Squibb · NCT06561386A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · TBC Research · Uniquity One (UNI) · NCT06496620A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
Phase 3 · BRCR Global · Takeda · NCT07217301Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipol
Phase 2 · Segal Trials - West Broward Outpatient Research Site /ID# 27 · AbbVie · NCT07220460OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1044 · Anthos Therapeutics, Inc. · NCT05712200A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Phase 3 · LEO Pharma Investigational Site · LEO Pharma · NCT07335588Tissue Repair Gel in Venous Leg Ulcers (US)
Phase 3 · Clincial Research Site 51 · TR Therapeutics · NCT06707090Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer
Phase 1/Phase 2 · BRCR Global - Tamarac · Pfizer · NCT07227298A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · BRCR Medical Center Inc. · DualityBio Inc. · NCT05150691A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Phase 2 · FWD Clinical Research · Navigator Medicines, Inc. · NCT07384975Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · D&H Tamarac Research Center LLC · Pfizer · NCT05156398OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · FWD Clinical Research · Amgen · NCT07136012Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
NA · Barry University Clinical Research · Reprise Biomedical, Inc. · NCT06939673REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Particip
Phase 3 · Phoenix Clinical Research · Regeneron Pharmaceuticals · NCT07213778Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adul
Phase 2/Phase 3 · BRCR Global - Tamarac · Pfizer · NCT07226999MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · BRCR Global - Tamarac · Pfizer · NCT06152575Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Phase 2 · BRCR Global · Boehringer Ingelheim · NCT06581432A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Phase 3 · Dh Tamarac Research Center Etna Medical Center Emc · Incyte Corporation · NCT06548360A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melan
Phase 3 · Boca Raton Clinical Research (BRCR) Global · Regeneron Pharmaceuticals · NCT06246916
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.